Finance

Lists
Why is ENOV down ၂.၂၄%?
Dive Deeper
ENOV:NYSE
Enovis Corp
၁၈.၅၇ US$
-၂.၂၄%
(-၀.၄၃) 1D
၁၈.၅၇ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၄, GMT-၄ ၁၆:၀၀:၀၅  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENOV...
Open
၁၈.၇၄ US$
High
၁၈.၈၅ US$
Low
၁၈.၂၄ US$
Mkt. cap
၁၀၇.၀၉ ဋေ
Avg. vol.
၁.၉၈ သန်း
Volume
၁.၁၄ သန်း
52-wk high
၃၄.၂၈ US$
52-wk low
၁၆.၇၀ US$
EPS
-၁၉.၂၇ US$
Beta
၁.၁၄
Shares outstanding
၅.၇၇ ကုဋေ
No. of employees
၈ ထောင်
Open
၁၈.၇၄ US$
High
၁၈.၈၅ US$
Low
၁၈.၂၄ US$
Mkt. cap
၁၀၇.၀၉ ဋေ
Avg. vol.
၁.၉၈ သန်း
Volume
၁.၁၄ သန်း
52-wk high
၃၄.၂၈ US$
52-wk low
၁၆.၇၀ US$
EPS
-၁၉.၂၇ US$
Beta
၁.၁၄
Shares outstanding
၅.၇၇ ကုဋေ
No. of employees
၈ ထောင်
News stories
From web sources and news partners
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၂ ရက်
Needham cuts Enovis stock price target on robotics deal impact
GuruFocus
GuruFocus
·
ပြီးခဲ့သည့် ၂ ရက်
ENOV Maintains Buy Rating by Needham -- Price Target Lowered to $34
Profile
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Dallas, Texas and is listed on the NYSE as ENOV. The company has over 8,000 employees operating at 30 sites around the world. Wikipedia
About Enovis Corp
CEOMatthew L. Trerotola
Employees၇.၈ ထောင်
Founded၁၉၉၅
HeadquartersWilmington, ဒယ်လာဝဲပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteenovis.com
Analyst ratings
Based on 11 analysts giving stock ratings to ENOV in the past 3 months
Strong buy
Buy
10
Hold
1
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ENOV in the last 3 months.
Highest
Current ၁၈.၅၇ US$
၄၇.၀၀ US$ (+၁၅၃.၁၀%)
Average
၃၆.၂၀ US$ (+၉၄.၉၄%)
Lowest
၂၇.၀၀ US$ (+၄၅.၄၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Matson
Needham
Buy
Maintained
၃၄.၀၀ US$
+၈၃.၁%
10/12/2026
Patrick Wood
UBS
Buy
Maintained
၄၄.၀၀ US$
+၁၃၆.၉%
10/05/2026
Ryan Zimmerman
BTIG
Buy
Maintained
၃၆.၀၀ US$
+၉၃.၉%
10/02/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
၃၃.၀၀ US$
+၇၇.၇%
09/08/2026
Caitlin Cronin
Canaccord Genuity
Buy
Reiterated
၄၅.၀၀ US$
+၁၄၂.၃%
09/01/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
၄၅.၀၀ US$
+၁၄၂.၃%
09/01/2026
David Turkaly
Citizens JMP
Buy
Maintained
၄၇.၀၀ US$
+၁၅၃.၁%
09/02/2026
Vik Chopra
BMO Capital
Buy
Reiterated
၂၇.၀၀ US$
+၄၅.၄%
09/01/2026
Keith Hinton
Freedom Capital Markets
Buy
Maintained
၃၆.၀၀ US$
+၉၃.၉%
09/01/2026
Steven Lichtman
William Blair
Buy
Maintained
-
-
08/14/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
၂၈.၀၀ US$
+၅၀.၈%
08/10/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
၃၂.၀၀ US$
+၇၂.၃%
08/07/2026
Rong Li
Jefferies
Buy
Reiterated
၄၀.၀၀ US$
+၁၁၅.၄%
07/14/2026
Unknown Analyst
Jefferies
Buy
Reiterated
၄၀.၀၀ US$
+၁၁၅.၄%
07/14/2026
Unknown Analyst
BMO Capital
Buy
Initiated
၂၉.၀၀ US$
+၅၆.၂%
07/09/2026
Jeff Johnson
Robert W. Baird
Buy
Maintained
၃၇.၀၀ US$
+၉၉.၂%
05/08/2026
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q2 2026
၀.၉၀ US$ / ၀.၈၅ US$
+၆.၃၄%beat
Revenue / Est. (USD)
၅၈.၂၈ ကုဋေ / ၅၈.၁၈ ကုဋေ
+၀.၁၆%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ အောက်
၂၀၂၅ ဒီ
၂၀၂၆ ဧ
၂၀၂၆ ဇူ
Revenue
၅၄.၈၉ ကုဋေ
၅၇.၅၈ ကုဋေ
၅၈.၉၂ ကုဋေ
၅၈.၂၈ ကုဋေ
Cost of goods sold
၂၁.၈၅ ကုဋေ
၂၂.၂၇ ကုဋေ
၂၂.၃၇ ကုဋေ
၂၂.၃၅ ကုဋေ
Cost of revenue
၂၁.၈၅ ကုဋေ
၂၂.၂၇ ကုဋေ
၂၂.၃၇ ကုဋေ
၂၂.၃၅ ကုဋေ
Research and development expenses
၂.၉၇ ကုဋေ
၃.၁၄ ကုဋေ
၃.၁၅ ကုဋေ
၃.၁၇ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၄.၅၄ ကုဋေ
၂၄.၉၈ ကုဋေ
၂၇.၀၆ ကုဋေ
၂၆.၁၆ ကုဋေ
Operating expense
၃၁.၈၈ ကုဋေ
၃၂.၆၄ ကုဋေ
၃၄.၄၀ ကုဋေ
၃၃.၄၉ ကုဋေ
Total operating expenses
၅၃.၇၃ ကုဋေ
၅၄.၉၁ ကုဋေ
၅၆.၇၇ ကုဋေ
၅၅.၈၄ ကုဋေ
Operating income
၁.၁၆ ကုဋေ
၂.၆၇ ကုဋေ
၂.၁၅ ကုဋေ
၂.၄၄ ကုဋေ
Other non operating income
၄.၄၈ သိန်း
၁.၉၃ သန်း
၃.၂၇ သန်း
-၁.၉၁ သန်း
EBT including unusual items
-၅၆.၆၉ ကုဋေ
-၅၀.၉၅ ကုဋေ
၆.၃၄ သိန်း
၇.၄၆ သန်း
EBT excluding unusual items
၃.၁၈ သန်း
၂.၁၁ ကုဋေ
၁.၅၆ ကုဋေ
၁.၄၄ ကုဋေ
Income tax expense
၄.၀၀ သန်း
၉.၂၆ သန်း
၉.၀၄ သန်း
၈.၅၀ သန်း
Effective tax rate
-၀.၇၁%
-၁.၈၂%
၁,၄၂၆.၆၆%
၁၁၃.၈၈%
Other operating expenses
-
-
-
-
Net income
-၅၇.၁၁ ကုဋေ
-၅၂.၀၆ ကုဋေ
-၈.၇၆ သန်း
-၁.၁၉ သန်း
Net profit margin
-၁၀၄.၀၅%
-၉၀.၄၂%
-၁.၄၉%
-၀.၂၀%
Earnings per share
၀.၇၅
၀.၉၅
၀.၈၉
၀.၉၀
Interest and investment income
၁.၂၀ ကုဋေ
၁.၂၆ ကုဋေ
၁.၀၀ ကုဋေ
၁.၀၅ ကုဋေ
Interest expense
-၂.၀၈ ကုဋေ
-၂.၀၁ ကုဋေ
-၁.၉၂ ကုဋေ
-၁.၈၅ ကုဋေ
Net interest expenses
-၈.၈၃ သန်း
-၇.၅၁ သန်း
-၉.၁၇ သန်း
-၈.၀၄ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
၈.၅၉ ကုဋေ
၁၀.၃၇ ကုဋေ
၉.၄၈ ကုဋေ
၉.၅၄ ကုဋေ
Gain or loss from assets sale
၂.၈၁ သိန်း
၃.၂၉ သိန်း
-၇.၅၀ သောင်း
၈.၄၃ သိန်း
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ